heart failure glp 1 GLP-1RAs reduce cardiovascular deaths in patients with CKM comorbidity | Duke Clinical Research Institute posted on the topic Effects of Glucagon-Like Peptide 1

Biohacker Protocol (experimental) Dose: 0.5 mg Tesamorelin + 100 mcg Ipamorelin Duration: Continuous (12+ weeks) Frequency: 5 days on, 2 days off Cycle Interval: No fixed washout

Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World Company profiles of the GLP-1 Analogues market and the growth strategies adopted by the market players to sustain the fast-growing market

Patients who lose more than 20% of their body weight experience alopecia at a rate of 5.3%

On average, patients using Semaglutide or Tirzepatide for 68 weeks without diet or exercise lost 15% (Semaglutide) and 20% (Tirzepatide) of their body weight in clinical studies

FDA.gov (accessed 26 July 2025)

These are given twice a week or thrice a week, or once a month